Login to Your Account



UK Preps for Value-Based Drug Pricing Plan Talks

By Nuala Moran
BioWorld International Correspondent

Wednesday, January 4, 2012
LONDON – The UK pharma and biotech industry is gearing up for the start of negotiations with Department of Health officials on a new value-based drug pricing scheme, which is due to replace the current cost-plus system that has been in force for more than 50 years.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription